SCHEMBL29638669

SCHEMBL29638669

Cc1ccc2c(Nc3cc(S(C)(=O)=O)ccc3F)nccc2c1N1CN=C(N)c2ccccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNNI3K Q59H18 2/20 0.35
TGFBR1 P36897 5/20 0.34
MAP4K4 O95819 4/20 0.34
P2RX7 Q99572 2/20 0.33
PIP4K2A P48426 2/20 0.32
PIP4K2C Q8TBX8 2/20 0.32
RIPK2 O43353 2/20 0.32
KDR P35968 2/20 0.32
RET P07949 1/20 0.32
MAPK14 Q16539 1/20 0.32
PKMYT1 Q99640 1/20 0.32
PIP4K2B P78356 1/20 0.31
ALDH3A1 P30838 1/20 0.31
CDK4 P11802 2/20 0.31
CDK2 P24941 2/20 0.31
CCNE1 P24864 1/20 0.30
PTK6 Q13882 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
PIM1 P11309 1/20 0.30
PIM2 Q9P1W9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638490 0.83 MAPK14 (0.31) MAPK14
SCHEMBL29638645 0.82 BRAF (0.33) KDRMAPK14
SCHEMBL24399571 0.78 TNNI3K (0.43) TNNI3KTGFBR1MAP4K4P2RX7RIPK2
SCHEMBL30559487 0.78 TNNI3K (0.43) TNNI3KTGFBR1MAP4K4P2RX7RIPK2
SCHEMBL29638666 0.78 MAPK1 (0.36) KDRPIM1PIM2
SCHEMBL29638749 0.77 BRAF (0.38) TGFBR1KDR
SCHEMBL29638518 0.76 FGFR1 (0.36) KDRMAPK14PIM1PIM2
SCHEMBL29638623 0.73 KDM1A (0.38) KDR
SCHEMBL29638508 0.72 BRAF (0.35) MAP4K4KDRTDP1
SCHEMBL25373487 0.72 ALDH3A1 (0.47) TNNI3KTGFBR1MAP4K4P2RX7RIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 WO disclosed